Published in Cancer Weekly, October 18th, 1999
S.H. Hautmann and colleagues from the University of Miami, Florida, evaluated the effectiveness and toxicity of local continuous immunotherapy for prostatic cancer. Their results were reported in the journal Anticancer Research ("Local Intratumor Immunotherapy of Prostate Cancer with Interleukin-2 Reduces Tumor Growth," Anticancer Research, 1999;19:2661-2663).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.